Care Access Acquires CEMEC to Expand Clinical Research in Brazil and Latin America
Care Access, a global healthcare and research company, has announced the acquisition of Centro Multidisciplinar de Estudos Clínicos (CEMEC), one of Brazil’s leading clinical research centers. Known for its innovative approach to conducting large multicenter studies, CEMEC specializes in pharmaceutical research and has played a pivotal role in advancing clinical trials across Brazil. This acquisition is a key milestone in it’s’ strategy to expand its presence and research capabilities in Latin America, offering enhanced opportunities for new medicines and vaccines.
Expanding Research Opportunities in Latin America
The acquisition of CEMEC represents a significant part of Care Access’ broader strategy to increase access to clinical research across Latin America. This move follows the company’s previous successes, including the acquisition of the Instituto Brasil de Pesquisa Clínica (IBPClin) in 2022. It also complements the opening of a new Care Access research center in Xerém, located in Rio de Janeiro, in 2024, and plans for another research center in São Paulo set to open in May 2025.
As part of its continued expansion, is planning additional research centers throughout Brazil, Argentina, and other Latin American countries. The company also aims to expand its mobile clinics and a logistics hub to further extend its reach, making clinical trials more accessible to underserved communities in the region.
Strengthening CEMEC’s Impact in Brazil
With this acquisition, CEMEC—which operates a large research center in São Bernardo do Campo—gains additional resources and operational support to further its mission of providing access to clinical trials and improving healthcare in Brazil. CEMEC has been instrumental in conducting phase 2, 3, and 4 clinical studies in a wide range of therapeutic areas. The research center is managed by a highly skilled multidisciplinary team and has successfully conducted more than 100 clinical studies in 18 therapeutic areas since its inception.
By joining forces with Care Access, CEMEC will enhance its capabilities, particularly in expanding access to research and improving patient recruitment, especially in remote and underserved areas of Brazil. Rodrigo Pavani, co-owner of CEMEC, highlighted the importance of this partnership, stating, “We are excited to bring Care Access’ resources to our research center here in Brazil, where many find it difficult to access clinical trial opportunities.”
Care Access’ Commitment to Community-Based Research
Care Access is well known for its innovative approaches to clinical trial delivery. The company’s Future of Medicine program accelerates participation in clinical trials by making research more accessible and reducing barriers to entry for underserved communities. This program aims to bring health screenings and research opportunities to remote and underserved populations, ultimately ensuring better representation in clinical trials. By doing so, it ensures that clinical trials better reflect real-world populations, which leads to more accurate and comprehensive medical data.
Care Access’ commitment to this model aligns seamlessly with CEMEC’s mission of expanding research access and improving healthcare outcomes across Brazil. The integration of it’s’ mobile health clinics and innovative research methodologies will allow CEMEC to extend its reach beyond urban centers and into more remote areas of the country.
Enhancing Health Outcomes and Access
Ahmad Namvargolian, CEO and Co-Founder, emphasized the importance of expanding the company’s footprint in Latin America. He said, “Some of the world’s best research centers are located there, and research opportunities are expanding rapidly in the region. CEMEC represents the gold standard for clinical research excellence in Brazil. By combining CEMEC’s established presence and expertise with Care Access’ strategic and operational support, we will bring high-quality research and care to even more communities and ultimately improve health outcomes for more people.”
This partnership will also benefit the Brazilian communities served by CEMEC. It plans to enhance healthcare access by integrating research education and offering a wider range of health services to these communities. Through the Future of Medicine program, patients will have increased opportunities to participate in cutting-edge research, which could lead to more treatment options becoming available in the near future.
Key Benefits of the Acquisition
This acquisition will bring several key advantages to CEMEC and the wider Brazilian healthcare system:
1. Increased Accessibility Through Mobile Health Clinics
Care Access’ fleet of mobile health clinics will play a crucial role in extending research participation opportunities to communities in São Paulo and the surrounding areas. These mobile units will facilitate convenient access to clinical trials, ensuring that patients from remote areas can easily participate.
2. Comprehensive Research and Education Programs
The Future of Medicine program, integrated into CEMEC’s operations, will offer health education and research training to the local population. This program will not only provide clinical trial opportunities but also increase public understanding of clinical research, improving recruitment efforts and participation in studies.
3. Global Expertise and Operational Support
CEMEC will gain the support of global network of more than 1,000 clinical research professionals. This will significantly enhance the research center’s operational capacity, allowing it to conduct larger, more complex studies with better resources and expertise.
4. Expansion of Research in New Therapeutic Areas
CEMEC’s ability to conduct clinical trials across a wide range of therapeutic areas will be amplified by Care Access’ support. This expanded capacity will enable the research center to participate in high-priority studies, particularly those related to new medicines and vaccines that are vital to improving health outcomes in the region.
The Future of Clinical Research in Latin America
As Care Access continues to expand its presence across Latin America, the acquisition of CEMEC is poised to have a lasting impact on the region’s clinical research landscape. By combining innovative community-based research model with CEMEC’s local expertise, the partnership will make clinical trials more accessible to diverse populations and drive the development of treatments for a range of health conditions.
The goal is not only to conduct more studies but to create a sustainable model that promotes health equity by bringing cutting-edge healthcare services to underserved areas. This will ultimately lead to better health outcomes for the communities involved and a more inclusive approach to clinical research in Latin America.
Conclusion
The acquisition of CEMEC by Care Access is a significant step in advancing clinical research and healthcare access in Brazil and throughout Latin America. By combining CEMEC’s expertise with Care Access’ innovative research methodologies, the partnership will help improve research participation, expand access to new treatments and vaccines, and enhance overall health outcomes in the region. With additional research centers planned and a growing network of mobile clinics, Care Access is poised to make a lasting impact on clinical research accessibility in Latin America.
About Care Access
Care Access works around the world to make the future of health better for everyone. We help people learn more about their health, access the health resources they need, and participate in research to help find new medicines and cures.
With more than 200 research centers around the world, hundreds of traveling medical professionals, and a fleet of more than 150 mobile health clinics, we work with hundreds of communities each year to deliver care and research where it’s needed most. Through our Future of Medicine program , we provide our members with no-cost health screenings, clinical research information, education, and other services. And through our Difference Makers program , we support and amplify the impact of local leaders and organizations working to improve the health and well-being of their communities.
To learn more about Care Access, visit www.CareAccess.com .
